Clinical Trials on Coronary Bifurcation Stenosis

Total 10696 results

Abbott Medical Devices

Completed

A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population (SV JAPAN)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis

Japan
Azienda Ospedaliera Città della Salute e della...
University Hospital, Zürich

Completed

veRy Thin Stents for Patients With Left mAIn or bifurcatioN in Real Life: the RAIN a Multicenter Study (RAIN)

Left Main Coronary Artery Disease | Stent Thrombosis | Stent Restenosis | Coronary Bifurcations | Very Thin Stents

Italy
M.A. Med Alliance S.A.
Iqvia Pty Ltd

Recruiting

SELUTION SLR™ 014 In-stent Restenosis (SELUTION4ISR)

Coronary Restenosis

United States, France, Brazil, Italy, Netherlands, Belgium
ZhuHai Cardionovum Medical Device Co., Ltd.
R&G Pharma Studies Co.,Ltd.

Completed

Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis

Coronary Restenosis

China
Mitsui Memorial Hospital
Teikyo University; Tokai University

Unknown

Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis Lesions (ELEGANT)

Coronary Restenosis

Japan
Aziende Chimiche Riunite Angelini Francesco S.p.A

Completed

The Effects of Bindarit in Preventing Stent Restenosis

Coronary Restenosis

Italy
Sahajanand Medical Technologies Pvt. Ltd.
CMS Medical

Completed

Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

Coronary Restenosis

Brazil
The University of Hong Kong

Completed

EGO-COMBO Clinical End-point Extension Study Beyond 36 Months

Coronary Restenosis

China
University Hospital, Saarland

Completed

Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II)

Coronary Restenosis

Germany
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort) (XVU-LTF)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis

United States
University Hospital, Saarland

Completed

Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I)

Coronary Restenosis

Germany
University Hospital Ostrava

Completed

Treatment of In-Stent Restenosis 2 Study (TIS2)

Coronary Restenosis

Czechia
InnoRa GmbH

Completed

Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon

Coronary Restenosis

Switzerland, Germany
Deutsches Herzzentrum Muenchen

Completed

Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES (ISAR-DESIRE 3A)

Coronary Restenosis

Germany
The Cleveland Clinic

Completed

Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal

Coronary Restenosis

United States
Boston Scientific Corporation

Completed

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis (TAXUS V ISR)

Coronary Restenosis

United States, Canada
Deutsches Herzzentrum Muenchen

Completed

Oral Sirolimus for In-Stent Restenosis (OSIRIS)

Coronary Restenosis

Germany
HaEmek Medical Center, Israel

Terminated

AngioSculpt Scoring Balloon Catheter For Bifurcation Coronary Lesions (ABC Study) (ABC)

Bifurcation Coronary Disease

Israel
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis (RESTORE)

Coronary Restenosis

Korea, Republic of
Celgene Corporation

Completed

Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis (SNAPIST-III)

Coronary Restenosis
Abbott Medical Devices
Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Baim Institute...

Completed

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort (XVU-AV DAPT)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis

United States
Saint Luke's Health System
Asahi-Intecc

Recruiting

STAR and Deferred Stenting Study (STAR)

Coronary Occlusion | Coronary Stenosis | Coronary Restenosis

United States
Medical University of Silesia

Completed

PCI vs. CABG in UPLM-ISR (LM-DRAGON)

Left Main Coronary Artery Disease | Restenosis, Coronary | PTCA Left Main Artery Complications

Poland, Italy
Seoul National University Hospital

Unknown

Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial (mini-COREA)

Angioplasty, Transluminal, Percutaneous Coronary | Coronary Restenosis

Korea, Republic of
Abbott Medical Devices

Completed

Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period (XERES)

Coronary Restenosis

France
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis | Thrombosis (Stent Thrombosis)

China
Seoul National University Hospital

Completed

Mechanism and Predictor of Side Branch Jailing (PRESSURE)

Bifurcating Coronary Artery Lesions | Main Branch Stent Implantation | Side Branch Jailing

Korea, Republic of
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study (XV CHINA SAS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angioplasty

United States
Prof. Stephen Lee

Completed

OCT Evaluation of Healing of COMBO Stent (EGO-COMBO)

Coronary Thrombosis | Coronary Restenosis

Hong Kong
University Hospital, Saarland

Terminated

Efficacy of the SeQuent®Please in the Treatment of De-novo Stenoses Versus Taxus™Liberté™ (PEPCAD-DEBonly)

Coronary De-novo Stenoses

Germany
Cathreine BV
Catharina Ziekenhuis Eindhoven; St. Antonius Hospital; Medical Centre Leeuwarden and other collaborators

Recruiting

Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy (Hybrid DEB)

Coronary Artery Disease | Coronary Bifurcation Lesion

Netherlands
Abbott Medical Devices

Completed

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angina

Japan
Minneapolis Heart Institute Foundation

Recruiting

Progress Bifurcation Global Registry

Coronary Artery Disease | Coronary Bifurcation Lesions

United States
Kathirvel Subramaniam
Pacira Pharmaceuticals, Inc

Completed

Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride

Coronary Artery Disease | Valve Regurgitation, Tricuspid | Coronary Artery Stenoses | Valve Regurgitation, Mitral

United States
Fondazione Evidence per Attività e Ricerche Cardiovascolari...

Recruiting

AnGiographic Performance With A Sirolimus-elutiNG Balloon in the TrEatment of De Novo CoronaRy Artery Disease (GINGER)

Coronary Restenosis

Italy
Biotronik AG

Completed

Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis. (BIOLUX-RCT)

Coronary Artery Disease | Coronary Restenosis

Germany, Latvia
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ I)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Australia, Germany, France, Switzerland, Netherlands, United Kingdom, Portugal, Belgium, Denmark
Abbott Medical Devices

Completed

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Switzerland, Netherlands, Spain, France, Sweden, Poland, Germany, Belgium, Denmark, Italy, United Kingdom
Sarepta Therapeutics, Inc.
Baim Institute for Clinical Research

Completed

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

Coronary Artery Disease | Coronary Restenosis

Germany
Samsung Medical Center

Withdrawn

DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold (SMART-BRS-ISR)

Coronary Artery Disease | Coronary Restenosis

Korea, Republic of
SIS Medical AG

Suspended

Absorb BVS vs. Drug Coated Balloon for Treatment Of ISR (AbsorbISR)

Coronary Artery Disease | Coronary Restenosis

Switzerland
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Australia, New Zealand, Germany
Abbott Medical Devices

Completed

EXCEL Clinical Trial (Universal Registry) (EXCEL)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Left Main Coronary Artery Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis

United States
Scripps Health

Completed

SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents

Coronary Artery Disease | Coronary Restenosis

United States
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort B (ABSORB B)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Netherlands, Poland, France, Denmark, Australia, Switzerland, Belgium
Abbott Medical Devices

Completed

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels (ABSORB UK)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United Kingdom
Abbott Medical Devices

Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Thailand, Israel, Spain, Italy, United Kingdom, Malaysia, Austria, France, Germany, Poland
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland

Clinical Trials on Coronary Bifurcation Stenosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations